Sign In
NewsRadar

Press release centre

Search Press
Looking for press releases of a particular company? Enter company name (or keyword) here.
   

Past Press Releases - Santaris Pharma A/S (acquired by Roche)

August 4, 2014
Roche to acquire Santaris Pharma to expand discovery and development of RNA-targeting medicines
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has agreed to acquire Santaris Pharma,
a privately held biopharmaceutical company based near Copenhagen, Denmark. More

May 28, 2008
Santaris begins human clinical testing of the world’s first medicine targeted at a human microRNA
SPC3649 (LNA-antimiR-122) being developed as a potential new therapy for Hepatitis C virus (HCV) infection More

March 26, 2008
Nature publishes study by Santaris Pharma scientists and collaborators
Nature publishes study by Santaris Pharma scientists and collaborators: LNA-mediated microRNA silencing in non-human primates More

December 18, 2007
Santaris Pharma raises €20 million of new equity
Gilde Healthcare Partners joins existing shareholders, board directors and management in the Company’s Series C Investment Round. More

July 4, 2007
Santaris Pharma consortium awarded €1.35m
Santaris Pharma consortium awarded €1.35m by Denmark’s Advanced Technology Foundation for development of the first microRNA medicine. More

January 26, 2007
FDA approves Enzon IND for Santaris Pharma’s Second New Cancer Drug
Santaris Pharma, the Danish biopharmaceutical company, announced today that it has received a milestone payment of US$5 million from Enzon Pharmaceuticals Inc., its oncology partner, coinciding with the acceptance by the U.S. Food and Drug Administration (FDA) of the Investigational New Drug (IND) application for SPC/ENZ2968, an RNA antagonist of HIF-1α (hypoxia-inducible factor 1alpha), being developed by Enzon for commercialisation outside Europe. More

November 28, 2006
Santaris Pharma awarded Ernst & Young Entrepreneur of the Year 2006
Santaris Pharma, the Danish biopharmaceutical company developing RNA Targeted Medicines, announced that it has won Ernst & Young’s “Entrepreneur of the Year 2006” award in Denmark for the biotech category. More

May 1, 2006
Santaris Pharma: New MicroRNA Cancer Research Collaboration

  • Latest Science may bring Breakthroughs in Cancer Medicine
  • Biotech-University Team Receives Funding from Danish Advanced Technology Foundation More

    June 29, 2005
    Santaris Pharma raises EUR 4.4 million in interim funding
    Santaris Pharma, the Danish biopharmaceutical company developing gene-targeting drugs for the treatment of cancer, today announced that it has received additional financing of EUR 4.4 million from its lead investors More

  • Data


    26,609
    Tech investments
    From our Online Data Service
    17,183
    VC-backed companies
    From our Radar


    Recent Deals


    DATEAMOUNTSECTOR
    Nov 25€24.0MInternet commerce
    Jan 24€11.0MBiopharmaceuticals
    Jan 24N/ABiotechnology
    Jan 24€104.0MBusiness applications
    Jan 24€15.0MBiopharmaceuticals
    Jan 24€1.5MInternet services
    Jan 23€3.2MBusiness applications

    For information on Europe's most extensive database on technology funding click here!

    Events



    Press Releases


    May 28
    Identiq
    identiq raises $5m seed, launches privacy-first identity validation...

    Apr 29
    Nethone
    nethone raised over $1 million from innovation nest

    Oct 1
    The Link App
    the link app launches version 2.0

    Mar 29
    Addex Therapeutics
    addex sucessfully raises chf40 million in capital increase

    Jan 2
    Urban Jungle
    urban jungle raises £1m in seed funding to build tech-enabled home ...





    About usContact usLegal Information
    Copyright © 1999-2019
    Emerging Technology Research Europe Inc. All rights reserved.